Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Net Margin (2017 - 2025)

Catheter Precision has reported Net Margin over the past 9 years, most recently at 3217.65% for Q4 2025.

  • Quarterly Net Margin rose 402128.0% to 3217.65% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2576.43% through Dec 2025, up 261428.0% year-over-year, with the annual reading at 2098.05% for FY2025, 309267.0% up from the prior year.
  • Net Margin was 3217.65% for Q4 2025 at Catheter Precision, down from 1002.65% in the prior quarter.
  • Over five years, Net Margin peaked at 61600.0% in Q3 2021 and troughed at 168960.0% in Q2 2022.
  • The 5-year median for Net Margin is 3262.2% (2024), against an average of 17087.83%.
  • Year-over-year, Net Margin plummeted -16843771bps in 2022 and then skyrocketed 16731833bps in 2023.
  • A 5-year view of Net Margin shows it stood at 61600.0% in 2021, then tumbled by -374bps to 168960.0% in 2022, then skyrocketed by 100bps to 522.66% in 2023, then tumbled by -1285bps to 7238.93% in 2024, then skyrocketed by 56bps to 3217.65% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Net Margin are 3217.65% (Q4 2025), 1002.65% (Q3 2025), and 3022.64% (Q2 2025).